Edition:
United States

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

499.95INR
5:59am EDT
Change (% chg)

Rs-0.35 (-0.07%)
Prev Close
Rs500.30
Open
Rs504.70
Day's High
Rs504.70
Day's Low
Rs495.40
Volume
16,630
Avg. Vol
64,231
52-wk High
Rs694.00
52-wk Low
Rs469.85

Latest Key Developments (Source: Significant Developments)

Alembic Pharmaceuticals gets EU GMP certificate for audit conducted at Panelav
Thursday, 31 Aug 2017 08:22am EDT 

Aug 31 (Reuters) - Alembic Pharmaceuticals Ltd :Alembic Pharmaceuticals - gets EU GMP certificate for audit conducted at its formulation facility at Panelav from 8th to 10th Aug.  Full Article

Alembic Pharma Ltd says sold Baddi plant to Scott Edil Pharmacia Ltd
Wednesday, 23 Aug 2017 09:55am EDT 

Aug 23 (Reuters) - Alembic Pharmaceuticals Ltd ::Says sold Baddi, Solan plant to Scott Edil Pharmacia Ltd on slump sale basis.Alembic Pharmaceuticals says sold plant's turnover, networth is insignificant; co meets domestic formulations demand from Sikkim unit.  Full Article

Alembic Pharmaceuticals sells formulations manufacturing facility at Baddi to Scott Edil Pharmacia
Wednesday, 23 Aug 2017 09:12am EDT 

Aug 23 (Reuters) - Alembic Pharmaceuticals Ltd :Alembic pharmaceuticals says sold on slump sale basis its formulations manufacturing facility at Baddi, dist. Solan to Scott Edil Pharmacia Limited.  Full Article

India's Alembic Pharmaceuticals says fire at Algerian JV plant
Friday, 18 Aug 2017 07:29am EDT 

Aug 18 (Reuters) - Alembic Pharmaceuticals Ltd :Says there was a fire incident at Algerian joint venture plant at Constantine, Algeria Constantine, Algeria.Says fire has had been brought under control.Says no casualties or injury to any persons is reported.Says do not expect a major adverse impact; co expects disruption in operations till plant is put back on stream.Says cause of accident and extent of damage is being investigated and assessed.  Full Article

Alembic Pharmaceuticals gets U.S. FDA approval for Doxycycline Capsules USP, 75 mg & 100 mg
Monday, 31 Jul 2017 12:46am EDT 

July 31 (Reuters) - Alembic Pharmaceuticals Ltd ::Says Alembic Pharmaceuticals Limited receives USFDA approval for Doxycycline Capsules USP, 75 mg and 100 Mg..Says drug is indicated treatment for for infections caused by bacteria.  Full Article

India's Alembic Pharma June-qtr consol PAT falls
Thursday, 20 Jul 2017 05:00am EDT 

July 20 (Reuters) - Alembic Pharmaceuticals Ltd : :June quarter consol profit after tax 633.8 million rupees versus 1.04 billion rupees year ago.June quarter consol total income 6.48 billion rupees versus 7.37 rupees year ago.  Full Article

India's Alembic Pharma gets FDA nod for generic hypertension drug
Tuesday, 18 Jul 2017 02:41am EDT 

July 18 (Reuters) - Alembic Pharmaceuticals Ltd ::Says ‍received U.S. food & drug administration (USFDA) approval for olmesartan medoxomil and amlodipine tablets​.  Full Article

Alembic Pharmaceuticals gets FDA tentative approval for vardenafil hydrochloride orally disintegrating tablets
Tuesday, 4 Jul 2017 01:10am EDT 

July 4 (Reuters) - Alembic Pharmaceuticals Ltd :Co got US Food & Drug Administration (USFDA) tentative approval for vardenafil hydrochloride orally disintegrating tablets.Says vardenafil hydrochloride orally disintergrating tablets are indicated for the treatment of erectile dysfunction.  Full Article

Alembic Pharmaceuticals gets U.S. FDA approval for amantadine hydrochloride capsules, USP
Thursday, 22 Jun 2017 12:02am EDT 

June 22 (Reuters) - Alembic Pharmaceuticals Ltd :Says received U.S. Food & Drug Administration (USFDA) approval for amantadine hydrochloride capsules, USP.  Full Article

Alembic Pharmaceuticals gets USFDA approval for hypertension drug
Wednesday, 21 Jun 2017 12:46am EDT 

June 21 (Reuters) - Alembic Pharmaceuticals Ltd :Says received US Food & Drug Administration (USFDA) approval for Candesartan Cilexetil tablets 32mg.Says drug used for treatment of hypertension.  Full Article

BRIEF-Alembic Pharmaceuticals gets EU GMP certificate for audit conducted at Panelav

* Alembic Pharmaceuticals - gets EU GMP certificate for audit conducted at its formulation facility at Panelav from 8th to 10th Aug Source text for Eikon: Further company coverage: